Advertisement

Topics

Soligenix, Inc. Company Profile

04:40 EDT 19th March 2019 | BioPortfolio

Soligenix, Inc. (Soligenix) is a late-stage biopharmaceutical company developing products to treat life-threatening side effects of cancer treatments and serious gastrointestinal diseases, and vaccines for certain bioterrorism agents. Soligenix's lead product, orBec(®) (oral beclomethasone dipropionate or BDP), is a potent, locally acting corticosteroid being developed for the treatment of acute gastrointestinal Graft-versus-Host-Disease (GI GVHD), a common and potentially life-threatening complication of hematopoietic cell transplantation. orBec(®) is currently the subject of a confirmatory Phase 3 clinical trial for the treatment of acute GI GVHD and an NIH-supported, Phase 2, randomized, double-blind, placebo-controlled trial in the prevention of acute GVHD. Soligenix has also recently initiated an NIH-supported Phase 1/2 clinical trial of SGX201 in the prevention of acute radiation enteritis. Additionally, Soligenix has a Lipid Polymer Micelle (LPM(TM)) drug delivery technology for the oral delivery of leuprolide for the treatment of prostate cancer and endometriosis.


News Articles [8 Associated News Articles listed on BioPortfolio]

Soligenix Announces Recent Accomplishments And Third Quarter 2018 Financial Results

PRINCETON, N.J., Nov. 9, 2018 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products Read...

Soligenix must enroll more people in Phase 3 test to treat lymphoma, prompting shares to tumble

Company said it has sufficient funds to fund the additional study

Soligenix shares soar thanks to new European patent

The patent boosts intellectual property protection around the company’s lead innate defense regulator, dusquetide, the active ingredient in its drug SGX942, which treats oral mucositis in patients w...

$SNGX Announces Publication Demonstrating Thermostabilization of an Ebola Subunit Vaccine Candidate https://www.prnewswire.com/news-releases/soligenix-announces-publication-demonstrating-thermostabilization-of-an-ebola-subunit-vaccine-candidate-300791086.

$SNGX Announces Publication Demonstrating Thermostabilization of an Ebola Subunit Vaccine Candidate https://www.prnewswire.com/news-releases/soligenix-announces-publication-demonstrating-thermostabi...

Small-Cap Snapshot: Krystal Biotech shares pop on optimistic early results from new gene therapy treatment

Small cap names on the move today are: Krystal Biotech (NASDAQ:KRYS), Soligenix (NASDAQ:SNGX), SELLAS Life Sciences Group Inc (NASDAQ:SLS), AcelRx Pharmaceuticals Inc (NASDAQ:ACR...

$SNGX will present Ricin Vaccine and Dusquetide Oral Mucositis Programs at the 2018 NORD Rare Diseases and Orphan Products October 15-16 https://www.prnewswire.com/news-releases/soligenix-announces-poster-presentations-of-its-ricin-vaccine-and-dusquetide

$SNGX will present Ricin Vaccine and Dusquetide Oral Mucositis Programs at the 2018 NORD Rare Diseases and Orphan Products October 15-16 https://www.prnewswire.com/news-releases/soligenix-announces...

NIH Selects Biopharma's Lead Asset for Commercialization Accelerator Program

Source: Streetwise Reports   09/26/2018 A Maxim Group analyst reported on news and upcoming catalysts for this late-stage drug developer.In a Sept. 13 research note, Maxim...

Soligenix Inc SNGX Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09112018] Prices from USD $250

SummarySoligenix Inc Soligenix is a latestage biopharmaceutical company which focuses on the development of products for the treatment of serious inflammatory diseases and biodefense counter measures....

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

Soligenix, Inc.

Soligenix, Inc. (Soligenix) is a late-stage biopharmaceutical company developing products to treat life-threatening side effects of cancer treatments and serious gastrointestinal diseases, and vaccine...

More Information about "Soligenix, Inc." on BioPortfolio

We have published hundreds of Soligenix, Inc. news stories on BioPortfolio along with dozens of Soligenix, Inc. Clinical Trials and PubMed Articles about Soligenix, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Soligenix, Inc. Companies in our database. You can also find out about relevant Soligenix, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...


Corporate Database Quicklinks



Searches Linking to this Company Record